What is the appropriate management of ureteral stones in a patient during the third trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Ureteral Stones in Third Trimester Pregnancy

For pregnant women with ureteral stones in the third trimester, initial management should be observation with trial of passage if symptoms are well-controlled, but ureteroscopy (URS) should be offered as definitive treatment when conservative management fails or symptoms are intractable. 1

Diagnostic Approach

Ultrasound is the mandatory first-line imaging modality 2, though it has limited sensitivity (45%) for ureteral stones 2. When ultrasound results are equivocal and clinical suspicion remains high:

  • Low-dose CT should be used as the last-line option 2
  • MRI serves as the second-line imaging choice 2
  • Avoid routine radiography (KUB) due to radiation exposure

Initial Management Strategy

Conservative Management (First-Line)

Observation with trial of passage should be offered when symptoms are well-controlled 1. However, counsel patients that:

  • Stone passage rates are only 40-60% during pregnancy 1
  • Mean time to passage is 17-35 days 1
  • Delayed intervention may ultimately be required 1

Medical expulsive therapy with tamsulosin has not demonstrated significant benefit in promoting stone passage during pregnancy 1, though it appears safe for mother and fetus.

Pain Management

  • NSAIDs are contraindicated in the third trimester due to risk of premature ductus arteriosus closure
  • Use opioids (hydromorphine, pentazocine, or tramadol preferred over pethidine) 2
  • Acetaminophen as adjunct

Indications for Intervention

Proceed to surgical intervention when:

  • Persistent pain unresponsive to conservative management 1, 3
  • Intractable symptoms 1
  • Signs of infection/sepsis 2
  • Progressive hydronephrosis 3
  • Uterine contractions 4
  • Obstruction of solitary kidney 2

Surgical Management Options

Ureteroscopy (Preferred Definitive Treatment)

URS is safe and effective during pregnancy with no increased endoscopic complications compared to non-pregnant patients 1. The evidence strongly supports this approach:

  • Stone-free rates exceed 94% across all series 5
  • Success rates of 100% reported in multiple studies 3, 4
  • Obstetric complication risk is 4.3% (preterm labor), consistent with non-urologic surgery during pregnancy 1
  • Can be performed with rigid 7.0F or 9.5F ureteroscopes without ureteral dilation 6
  • Holmium laser or pneumatic lithotripsy are safe energy sources 3, 4

Key technical considerations:

  • Coordinate with obstetrics team per ACOG recommendations 1
  • Use only ultrasound guidance for double-J stent placement (avoid fluoroscopy) 6
  • Neuroleptic analgesia often sufficient; general anesthesia not always required 6
  • Most stones in pregnancy are distal ureteral (58.8-79%) 3, 4

Temporary Drainage (Alternative)

Ureteral stent or percutaneous nephrostomy may be offered as temporizing measures 1, particularly when:

  • Patient declines definitive treatment
  • Stone cannot be reached during URS
  • Immediate symptom relief needed before definitive treatment

Important caveats:

  • Requires frequent exchanges (typically every 6 weeks) 7
  • Most patients ultimately require post-delivery intervention 5
  • Stent-related symptoms (bladder irritation) common 3
  • Primary URS is more efficient than temporary drainage followed by delayed treatment 5

Emergency Management

For sepsis and/or anuria with obstruction, urgent decompression via nephrostomy or ureteral stent is mandatory 2. In this scenario:

  • Obtain urine cultures before and after decompression 2
  • Start empiric antibiotics immediately 2
  • Delay definitive stone treatment until sepsis resolves 2

Common Pitfalls to Avoid

  • Do not delay medically necessary surgery - ACOG states surgery should not be denied regardless of trimester 1
  • Do not use NSAIDs in third trimester - risk of premature ductus arteriosus closure
  • Do not routinely use fluoroscopy - ultrasound guidance is sufficient for stent placement 6
  • Do not assume conservative management will succeed - only 40-60% passage rate 1
  • Do not choose temporary drainage as definitive management - most require subsequent intervention 5

The evidence consistently demonstrates that URS is both safe and more efficient than temporizing measures, making it the preferred approach when intervention is indicated 1, 5.

Related Questions

How should ureteric stone pain be managed in a pregnant woman?
How does the anatomic location of a ureteral stone determine medical and surgical management?
How should symptomatic nephrolithiasis (renal colic) be managed in a woman in the third trimester of pregnancy?
In a 22‑week pregnant woman with normal renal function and a fetal cardiac lesion, which non‑magnesium urinary alkaliniser is recommended for managing kidney stones?
What is the recommended pain management for a pregnant patient in the second trimester with kidney stones?
What is the typical clinical course and recommended management of dengue in a previously healthy 6‑year‑old child?
Can Lunesta (eszopiclone) be combined with Belsomra (suvorexant)?
What is the recommended duration of azithromycin therapy for scarlet fever when penicillin cannot be used?
After a pancreaticoduodenectomy (Whipple procedure), what are the possible causes of a high fever, and could it be due to a pancreatic anastomotic leak or other postoperative complications?
Is it normal for a patient to feel more depressed and irritable within two days after increasing fluoxetine (Prozac) from 10 mg to 20 mg?
Which pharmacologic agents are first‑line for bipolar depression, what alternatives should be used if lurasidone (Latuda) has already been tried, how should acute mania be managed, which second‑generation antipsychotics are preferred for a patient with a history of akathisia and how can akathisia be treated beyond propranolol and mirtazapine, how is drug‑induced parkinsonism recognized and managed, what steps are taken for treatment‑resistant schizophrenia after adequate trials of risperidone and olanzapine, and when should naltrexone versus acamprosate be chosen for alcohol use disorder based on medical history and contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.